Hospital-acquired and community-acquired MRSA: Two distinct infections

Emergency Medicine

Volumn 41, Issue 10, 2009, Pages

  Seymour, Patricia ^a   Golding, Jeremy ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350662549     PISSN: 00136654     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med. 2005;352(5);468-475.
2. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003(5);36:592-598.
3. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53-59.
4. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46(suppl 5):s350-s359.
5. Ito R, Hiramatsu K. Acquisition of methicillin resistance and progression of multiantibiotic resistance in methicillin-resistant Staphylococcus aureus. Yonsei Med J. 1998;39(6):526-533.
6. Akoglu H, Zarakolu P, Altun B, et al. Molecular characterisation of hospital-acquired methicillin-resistant Staphylococcus aureus in a Turkish university hospital. 17th European Congress of Clinical Microbiology and Infectious Diseases; March 31-April 4, 2007; Munich, Germany. Abstract 1733_1071.
7. Lopez-Aguilar C, Perez-Roth E, Mendez-Alvarez S, et al. Association between the presence of the Panton-Valentine leukocidin-encoding gene and a lower rate of survival among hospitalized pulmonary patients with Staphylococcal disease. J Clin Microbiol. 2007;45(1):274-276.
8. Moran GJ, Krishnadasan A, Gorwitz RJ, et al; EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-674.
9. Beam JW, Buckley B. Community-acquired methicillin-resistant Staphylococcus aureus: prevalence and risk factors. J Athl Train. 2006;41(3):337-340.
10. French GL. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. J Antimicrob Chemother. 2006;58(6):1107-1117.
11. Ray SM, Farley MM, Ladson JL, et al. Invasive methicillin-resistant Staphylococcus aureus (MRSA) infections. Comparison of community-acquired and health care-associated (HA) disease. Program and abstracts of the Infectious Diseases Society of America 43rd Annual Meeting; October 6-9, 2005; San Francisco, California. Abstract 682.
12. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290(22):2976-2984.
13. Dominguez TJ. It's not a spider bite, it's community-acquired methicillin-resistant Staphylococcus aureus. J Am Board Fam Pract. 2004;17(3):220-226.
14. Nicolle L. Community-acquired MRSA: a practitioner's guide. CMAJ. 2006;175(2):145.
15. Zhanel GG, DeCorby M, Nichol KA, et al; Canadian Antimicrobial Resistance Alliance. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Diagn Microbiol Infect Dis. 2008;62(1):67-80.
16. Mulvey MR, MacDougall L, Cholin B et al; Saskatchewan CA-MRSA Study Group. Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis. 2005;11(6):844-850.
17. Lewis JS 2nd, Jorgensen JH. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis. 2005;40(2):280-285.
18. Jorgensen JH, Crawford SA, McElmeel ML, Fiebelkorn KR. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J Clin Microbiol. 2004;42(4):1800-1802.
19. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis. 2007;44(2):178-185.
20. Loeb M, Main C, Walker-Dilks C, Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev. 2003;(4):CD003340.
21. Steenbergen JN, Alder J, Thorne GM, Tally FP. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother. 2005;55(3):283-288.
22. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299(10):1149-1157